Methods for delivering volatile anesthetics for regional anesthesia and/or pain relief

US10357464B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10357464-B2
Application numberUS-201113183257-A
CountryUS
Kind codeB2
Filing dateJul 14, 2011
Priority dateSep 20, 2006
Publication dateJul 23, 2019
Grant dateJul 23, 2019

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present invention provides methods for reducing pain in a subject in need of such pain reduction by delivering, e.g., intrathecally or epidurally, a volatile anesthetic such as a halogenated ether compound in an amount effective to reduce pain. Chronic or acute pain may be treated, or the anesthetic may be delivered to the subject to anesthetize the subject prior to a surgery. In certain embodiments, isoflurane, halothane, enflurane, sevoflurane, desflurane, methoxyflurane, xenon, and mixtures thereof may be used. Dosing regimens including a one-time administration, continuous and/or periodic administration are contemplated.

First claim

Opening claim text (preview).

What is claimed is: 1. A method for reducing pain perception in a mammalian subject in need of such pain reduction, the method consisting of topically administering to the skin of said subject a topical patch consisting of sevoflurane and one or more pharmaceutically acceptable carriers in an amount effective to reduce pain perception in the subject, wherein the administering does not result in general anesthesia in the subject, and wherein the subject is not under general anesthesia; wherein the topical administration results in analgesia; wherein the volatile anesthetic is the only analgesic agent present in the pharmaceutical preparation in an amount sufficient to reduce pain in said subject; wherein the topical administration is not by inhalation; and wherein said topical administration reduces pain perception in the subject. 2. The method of claim 1 , wherein the method comprises treating chronic pain in the subject. 3. The method of claim 1 , wherein the method comprises treating acute pain in the subject. 4. The method of claim 1 , wherein the pharmaceutical preparation is delivered to anesthetize a portion of said subject prior to a surgery. 5. The method of claim 1 , wherein the administration is periodic. 6. The method of claim 1 , wherein the administration is a one-time event. 7. The method of claim 1 , wherein the volatile anesthetic is periodically administered to the subject on separate occasions. 8. The method of claim 1 , wherein the method results in elimination of pain perception of a portion of the body of the subject. 9. The method of claim 1 , wherein the subject is a human. 10. The method of claim 1 , wherein the subject is a mouse or a rat.

Assignees

Inventors

Classifications

  • Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] · CPC title

  • Centrally acting analgesics, e.g. opioids · CPC title

  • for peripheral neuropathies · CPC title

  • Anaesthetics · CPC title

  • Local anaesthetics · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10357464B2 cover?
The present invention provides methods for reducing pain in a subject in need of such pain reduction by delivering, e.g., intrathecally or epidurally, a volatile anesthetic such as a halogenated ether compound in an amount effective to reduce pain. Chronic or acute pain may be treated, or the anesthetic may be delivered to the subject to anesthetize the subject prior to a surgery. In certain em…
Who is the assignee on this patent?
Phan Phillip C, Burton Allen W, Univ Texas
What technology area does this patent fall under?
Primary CPC classification A61K31/02. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Jul 23 2019 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).